Home › Funds › Prudential Financial › IBRX
Prudential Financial position in IBRX
IMMUNITYBIO INC · Health Care
Latest position (Q2 2026)103.67K sh
Reported value held$907.63K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 104.62K | $1.02M | New |
| Q4 2021 | 75.36K | $459.00K | Reduce |
| Q2 2025 | 24.74K | $65.31K | New |
| Q3 2025 | 24.74K | $60.86K | Hold |
| Q4 2025 | 16.14K | $31.96K | Reduce |
| Q1 2026 | 268.37K | $2.06M | Add |
| Q2 2026 | 103.67K | $907.63K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IBRX
- BlackRock Inc 34.08M sh · $298.40M · Q2 2026
- D. E. Shaw & Co 11.55M sh · $101.13M · Q2 2026
- Two Sigma Investments 11.10M sh · $97.16M · Q2 2026
- Geode Capital Management 9.85M sh · $86.23M · Q2 2026
- Vanguard Group 32.78M sh · $64.90M · Q4 2025
- Millennium Management 5.58M sh · $48.85M · Q2 2026
- Northern Trust Corp 3.57M sh · $31.21M · Q2 2026
- Morgan Stanley 3.43M sh · $30.05M · Q2 2026
- Goldman Sachs Group 3.23M sh · $28.32M · Q2 2026
- UBS Group AG 3.20M sh · $27.98M · Q2 2026
- Charles Schwab Investment Management 2.89M sh · $25.29M · Q2 2026
- Bank of America Corp 2.18M sh · $19.13M · Q2 2026